Remote closed-loop titration of decongestive therapy for the treatment of advanced heart failure
US-2015141953-A1 · May 21, 2015 · US
US2016135734A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016135734-A1 |
| Application number | US-201514944626-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 18, 2015 |
| Priority date | Nov 19, 2014 |
| Publication date | May 19, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and apparatus provide evaluation of a cardiac condition of a patient with sleep disordered breathing. One or more processors, such as processors associated with any of ICDs, CRTs and/or respiratory pressure therapy devices, may be configured to receive data representing one or more respiratory parameters for the patient. The processor(s) may receive cardiac-related patient data for the patient. The processor(s) may determine a presence of a smooth hemodynamic baseline from the received data representing one or more respiratory parameters for the patient. The processors may evaluate the cardiac condition of the patient from the received cardiac-related patient data based on the determined presence of the smooth hemodynamic baseline.
Opening claim text (preview).
1 . A method for evaluating a cardiac condition of a patient with sleep disordered breathing comprising: receiving data representing one or more respiratory parameters for the patient; receiving cardiac-related patient data for the patient; determining in a processor a presence of a smooth hemodynamic baseline from the received data representing one or more respiratory parameters for the patient; and evaluating, with the processor, the cardiac condition of the patient from the received cardiac-related patient data based on the determined presence of the smooth hemodynamic baseline. 2 . The method of claim 1 wherein the determining comprises detecting absence of sleep disordered breathing events for a predetermined period of time. 3 . The method of claim 1 wherein the determining comprises: detecting sleep disordered breathing events; and controlling a respiratory therapy to alleviate the detected sleep disordered breathing events for a predetermined period of time. 4 . The method of claim 1 further comprising collecting, with one or more sensors, data representing one or more hemodynamic parameters for the patient while the patient is within the smooth hemodynamic baseline. 5 . The method of claim 4 , wherein the evaluating is based on the data representing one or more hemodynamic parameters. 6 . The method of claim 3 wherein the controlling comprises controlling a respiratory pressure therapy device to deliver respiratory pressure therapy for the patient. 7 . The method of claim 6 , wherein the respiratory pressure therapy comprises an adaptive servo-ventilation therapy. 8 . The method of claim 2 wherein the sleep disordered breathing events comprise one or more of apnea, hypopnea, Cheyne-Stokes respiration, snoring and flow limitation. 9 . The method of claim 3 , wherein the controlling comprises controlling an implanted device to provide at least one of genioglossal nerve stimulation and phrenic nerve stimulation. 10 . The method of claim 1 , further comprising determining, based on the evaluating, efficacy of a cardiac treatment that has been provided to the patient. 11 . The method of claim 10 , wherein the cardiac treatment comprises one or more of administering a pharmaceutical cardiac drug and application of a cardiac resynchronization therapy. 12 . The method of claim 10 , further comprising titrating the cardiac treatment according to the cardiac condition of the patient. 13 . The method of claim 12 wherein the titration of the cardiac treatment comprises determination of a diuretic dose. 14 . The method of claim 12 wherein the titration of the cardiac treatment comprises an adjustment to a target ventilation of a respiratory pressure therapy. 15 . The method of claim 14 wherein the respiratory pressure therapy is a pressure support ventilation therapy controlled in accordance with the target ventilation. 16 . The method of claim 5 wherein the evaluating comprises outputting one or more hemodynamic parameters according to a time period of the smooth hemodynamic baseline. 17 . The method of claim 5 wherein the evaluating comprises detecting a change in one or more hemodynamic parameters within a time period initiated with the smooth hemodynamic baseline. 18 . The method of claim 1 wherein the received cardiac-related patient data comprises measurements generated by a pulmonary artery sensor. 19 . The method of claim 1 wherein the received data representing one or more respiratory parameters comprises measurements generated by a Doppler radar motion sensor. 20 . A system for evaluating a cardiac condition of a patient with sleep disordered breathing comprising: one or more memories; and one or more processors in communication with the one or more memories, the one or more processors configured to: receive data representing one or more respiratory parameters for the patient; receive cardiac-related patient data for the patient; determine a presence of a smooth hemodynamic baseline from the received data representing one or more respiratory parameters for the patient; and evaluate the cardiac condition of the patient from the received cardiac-related patient data for the patient based on the determined presence of the smooth hemodynamic baseline. 21 . The system of claim 20 wherein determination of the presence of the smooth hemodynamic baseline comprises detecting absence of sleep disordered breathing events for a predetermined period of time. 22 . The system of claim 20 wherein determination of the presence of the smooth hemodynamic baseline comprises detecting sleep disordered breathing events and controlling a respiratory therapy to alleviate the detected sleep disordered breathing events for a predetermined period of time. 23 . The system of claim 20 further comprising collecting, with one or more sensors, cardiac-related patient data while the patient is within the smooth hemodynamic baseline. 24 . The system of claim 23 wherein evaluation of the cardiac condition is based on the cardiac-related patient data. 25 . The system of claim 20 further comprising a respiratory pressure therapy apparatus, the apparatus configured to alleviate detected sleep disordered breathing events by controlling a respiratory pressure therapy for the patient. 26 . The system of claim 25 , wherein the respiratory pressure therapy comprises an adaptive servo-ventilation therapy. 27 . The system of claim 21 wherein the sleep disordered breathing events comprise one or more of apneas, hypopneas, Cheyne-Stokes respiration, snoring, and flow limitation. 28 . The system of claim 20 , further comprising an implanted device configured to alleviate sleep disordered breathing events by controlling providing at least one of genioglossal nerve stimulation and phrenic nerve stimulation. 29 . The system of claim 20 , wherein the one or more processors is further configured to determine, based on the evaluating, efficacy of a cardiac treatment that has been provided to the patient. 30 . The system of claim 29 , wherein the cardiac treatment comprises one or more of administering a pharmaceutical cardiac drug and providing a cardiac resynchronization therapy. 31 . The system of claim 29 , wherein the evaluation further comprises titration of the cardiac treatment according to the cardiac condition of the patient. 32 . The system of claim 31 wherein the cardiac treatment comprises a diuretic dose and the titration comprises determining the diuretic dose. 33 . The system of claim 31 wherein the titration of the cardiac treatment comprises an adjustment to a target ventilation of a respiratory pressure therapy. 34 . The system of claim 33 wherein the respiratory pressure therapy is a pressure support ventilation therapy controlled in accordance with the target ventilation and provided by an adaptive servo-ventilator of the system. 35 . The system of claim 20 wherein the evaluation comprises outputting, by the one or more processors, one or more hemodynamic parameters according to a time period of the smooth hemodynamic baseline. 36 . The system of claim 20 wherein the evaluation comprises detecting by the one or more processors a change in
using physiological parameters · CPC title
the speed thereof being controlled by respiratory parameters, e.g. by inhalation · CPC title
Respiration control (stimulating respiratory organs A61N1/3601) · CPC title
Devices for facilitating collection of breath or for directing breath into or through measuring devices · CPC title
Sleep apnoea · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.